Successful long-term ibrutinib treatment in a hemodialysis patient with leukemic non-nodal mantle cell lymphoma
We report the first case of long-term ibrutinib administration in a hemodialysis patient with leukemic non-nodal mantle cell lymphoma (L-NN-MCL) in which ibr utinib therapy was both safe and effective.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Hajime Yasuda, Yutaka Tsukune, Tadaaki Inano, Yosuke Mori, Yasunori Ota, Norio Komatsu Tags: Case Report Source Type: research
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Dialysis | Hematology | Hemodialysis | Leukemia | Lymphoma | Macroglobulinemia | Myeloma | Waldenstrom's Macroglobulinemia